MENU

3 small-cap healthcare shares to buy today

medicine,

While most investors will be extremely familiar with blue chip healthcare shares such as Ramsay Health Care Limited (ASX: RHC) and CSL Limited (ASX: CSL), there are a number of small-cap healthcare shares on ASX which are flying under the radar.

I think the three small-cap shares listed below are well worth getting better acquainted with. Here’s why:

Medical Developments International Ltd (ASX: MVP)

I think this fast-growing healthcare company could have a very bright future thanks to the global expansion of its Penthrox pain management product. Management aims to make the green whistle product a mainstream analgesic of choice around the world and is well on its way to doing so. Over the next 12 months the company expects to have Penthrox approved for sale in more than 37 new countries around the world. I feel this is likely to lead to a significant lift in revenue over the next few years, which could make Medical Developments International a good buy and hold investment option.

National Veterinary Care Ltd (ASX: NVL)

I believe National Veterinary Care is in a strong position to deliver above-average earnings growth for the foreseeable future due to the high level of pet ownership in Australia and New Zealand and its growth through acquisition strategy. The company acquired and integrated 14 veterinary services businesses in FY 2017, including its first in New Zealand. This, along with its solid organic growth, helped lift full-year revenue by an impressive 51% to $66.9 million.

Zenitas Healthcare Ltd (ASX: ZNT)

I think this home care and health services company with 54 locations across Australia could be a big winner from Australia’s ageing population. Zenitas has a wide range of community-based health services that provide integrated care solutions with the aim of reducing the high cost of acute hospital care. In FY 2017 the company delivered pro forma EBITDA of $7 million, up 27.3% on FY 2016 and 6.1% greater than its prospectus forecast. Pleasingly, management expects this strong growth to continue in FY 2018 and has provided guidance of EBITDA in the range of $13 million to $13.5 million.

Finally, if you like growth shares like Zenitas, then I think you'll love these fast-growing blue-chips.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.